Search Results - "KARL, WORM"

Refine Results
  1. 1

    MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System by Teuber-Hanselmann, Sarah, Worm, Karl, Macha, Nicole, Junker, Andreas

    “…Quantifying O -methylguanine-DNA methyltransferase (MGMT) promoter methylation plays an essential role in assessing the potential efficacy of alkylating agents…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status by Broecker-Preuss, Martina, Müller, Stefan, Britten, Martin, Worm, Karl, Schmid, Kurt Werner, Mann, Klaus, Fuhrer, Dagmar

    Published in BMC cancer (26-03-2015)
    “…Patients with dedifferentiated or anaplastic thyroid carcinomas currently lack appropriate treatment options. Kinase inhibitors are among the most promising…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements by Sheu, Sien-Yi, Schwertheim, Suzan, Worm, Karl, Grabellus, Florian, Schmid, Kurt Werner

    Published in Modern pathology (01-07-2007)
    “…Diffuse sclerosing variant of papillary thyroid carcinoma (PTC) is a rare tumour with a characteristic morphology as well as a strong preponderance for younger…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon by Schmitz, Klaus Juergen, Hey, Sascha, Schinwald, Anja, Wohlschlaeger, Jeremias, Baba, Hideo Andreas, Worm, Karl, Schmid, Kurt Werner

    “…This study was designed to analyse the potential diagnostic value of miR-181b and miR-21 for discriminating hyperplastic polyps (HP) from sessile serrated…”
    Get full text
    Journal Article
  10. 10

    Defining tissue requirements for a reliable detection of tumor mutational burden (TMB) in clinical FFPE samples by Schildhaus, Hans-Ulrich, Herold, Thomas, Worm, Karl, Stoss, Oliver

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e14265 Background: In the context of immuno-oncology related cancer treatment, tumor mutational burden (TMB) is currently explored as a…”
    Get full text
    Journal Article
  11. 11

    Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells by Schwertheim, Suzan, Wein, Frederik, Lennartz, Klaus, Worm, Karl, Schmid, Kurt Werner, Sheu-Grabellus, Sien-Yi

    “…Purpose The therapy of unresectable advanced thyroid carcinomas shows unfavorable outcome. Constitutive nuclear factor-κB (NF-κB) activation in thyroid…”
    Get full text
    Journal Article
  12. 12

    Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2–7 gene deletion in human glioblastomas by Worm, Karl, Dabbagh, Peter, Schwechheimer, Karl

    Published in Human pathology (01-02-1999)
    “…Epidermal growth factor receptor (EGFR) gene amplification has been reported to occur in diverse carcinoma types such as lung, ovarian, and breast carcinomas…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Exercise during pregnancy mitigates Alzheimer‐like pathology in mouse offspring by Herring, Arne, Donath, Anja, Yarmolenko, Maksym, Uslar, Ellen, Conzen, Catharina, Kanakis, Dimitrios, Bosma, Claudius, Worm, Karl, Paulus, Werner, Keyvani, Kathy

    Published in The FASEB journal (01-01-2012)
    “…ABSTRACT Physical activity protects brain function in healthy individuals and those with Alzheimer's disease (AD). Evidence for beneficial effects of parental…”
    Get full text
    Journal Article
  15. 15

    Quantification of G Protein Gαs Subunit Splice Variants in Different Human Tissues and Cells Using Pyrosequencing by FREY, ULRICH H., NÜCKEL, HOLGER, DOBREV, DOBROMIR, MANTHEY, IRIS, SANDALCIOGLU, I. E., EISENHARDT, ANDREAS, KARL, WORM, HANS, HAUNER, SIFFERT, WINFRIED

    Published in Gene expression (01-02-2005)
    “…The G protein Gαs is derived from four alternatively spliced transcripts, two long variants (GαsL+CAG and GαsL−CAG), which include an extra 45-bp segment, and…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E) by Wohlschlaeger, Jeremias, Davidson, Ben, Worm, Karl, Feist, Henning, Peters, Jochen, Hager, Thomas, Schmid, Kurt W, Ostertag, Horst

    “…Papillomas of the fallopian tube are exceedingly rare benign tumors, and only very few cases have been reported in the literature. Clinically, they may present…”
    Get full text
    Journal Article
  19. 19

    Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients by Tiedje, Vera, Ting, Saskia, Walter, Robert Fred, Herold, Thomas, Worm, Karl, Badziong, Julia, Zwanziger, Denise, Schmid, Kurt Werner, Führer, Dagmar

    Published in European journal of endocrinology (01-09-2016)
    “…Objective Medullary thyroid carcinoma (MTC) occurs sporadically in 75% of patients. Metastatic disease is associated with significantly poorer survival. The…”
    Get full text
    Journal Article
  20. 20

    Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma by Pohl, Matthias, Grabellus, Florian, Worm, Karl, Arnold, Georg, Walz, Martin, Schmid, Kurt Werner, Sheu-Grabellus, Sien-Yi

    Published in Journal of clinical pathology (01-01-2017)
    “…Many studies have previously reported a higher prevalence of papillary thyroid carcinomas (PTC) in patients with Graves' disease (GD). MicroRNAs (miRNAs) are…”
    Get more information
    Journal Article